Screen Readers Skip to Content
Tweet Facebook Buffer

Accessible Prescription Drug Label Bill Signed by President Obama

Author: American Foundation for the Blind

Published: 2012-07-12

Synopsis:

Main Digest

President Obama Signs Landmark Accessible Prescription Drug Label Bill - AFB Applauds White House and Congress for Protecting the Safety of Americans with Vision Loss.

H.R. 4087 - Prescription Drug Labeling Promotion Act of 2012 - To provide for the development and dissemination of best practices to ensure that visually-impaired and blind individuals in the United States have safe, consistent, reliable, and independent access to the information in prescription drug labeling.

On July 9, President Barack Obama signed into law the Food and Drug Administration Safety and Innovation Act, which brings us a step closer to ensuring Americans with vision loss have access to the important information on their prescription labels. The Act includes provisions that establish national best practices for retail and other pharmacies to use in providing accessible prescription drug labeling to customers with vision loss. This includes proper dosage, the name of the medication, accompanying information about possible side effects, and more.

"We applaud President Obama and Congress for taking this important step," said Carl R. Augusto, president and CEO of the American Foundation for the Blind (AFB). "AFB has been working on this issue for many years and we're thrilled that this is now a reality."

The American Foundation for the Blind (AFB) has long championed safe and effective ways to address the significant public health challenge of inaccessible prescription drug labeling. Past studies have shown the dangers posed by the inability to access necessary instructions that accompany prescription and over-the-counter medications, including illness, emergency room visits and the reliance upon sighted companions - or even strangers.

"The significance of this measure cannot be understated," said Mark Richert, Director of Public Policy at the American Foundation for the Blind. "For the more than 20 million Americans living with vision loss, being unable to read drug container labels and package inserts is a scary reality."

The provisions in the Food and Drug Administration Safety and Innovation Act will serve as a valuable supplement to existing requirements under the Americans with Disabilities Act and other federal and state laws imposing obligations on pharmacies to ensure effective communication and barrier removal for people with disabilities. Whether this new legislation entails that medication instructions and inserts be available in large print, braille, or via an assistive technology device remains to be seen.

About AFB The American Foundation for the Blind - (AFB) is a national nonprofit that expands possibilities for people with vision loss. AFB's priorities include broadening access to technology; elevating the quality of information and tools for the professionals who serve people with vision loss; and promoting independent and healthy living for people with vision loss by providing them and their families with relevant and timely resources. Headquartered in New York, AFB is proud to house the Helen Keller Archives and honor the more than 40 years that Helen Keller worked tirelessly with AFB.

Related Documents


Important:

Disabled World uses cookies to help provide and enhance our services to you and tailor some content and advertising. By continuing you agree to the Disabled World Cookie Policy, Privacy Policy and Terms of Service.

Disabled World is strictly a news and information website provided for general informational purpose only and does not constitute medical advice. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World.

Please report outdated or inaccurate information to us.